Adenocor

Adenocor is a pharmaceutical preparation containing Adenosine, used for specific cardiovascular conditions. This intravenous medication is manufactured by Sanofi S.R.O. and is available in the EU market.

Adenocor, containing Adenosine, is primarily used in medical settings for the management of certain heart rhythm disorders. It is often administered intravenously to help restore normal heart rhythms. Adenosine is known for its rapid action in treating specific types of arrhythmias, making it a crucial medication in emergency cardiovascular care.

Adenocor may cause temporary side effects such as flushing, chest discomfort, or shortness of breath. These effects are usually short-lived and subside quickly. Patients may also experience a brief sensation of pressure or tightness in the chest immediately after administration.

Adenocor should be used with caution in patients with certain pre-existing heart conditions. It is essential to follow medical guidance when administering this medication. Patients with a history of asthma or other respiratory issues should inform their healthcare provider before use.

Adenocor may interact with certain medications, including those that affect heart rhythm or blood pressure. It is important to disclose all current medications to a healthcare provider to avoid potential interactions. Additionally, caffeine and other stimulants may influence the effectiveness of Adenosine.